The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Treatment of Infections Caused by Metronidazole-Resistant Trichomonas vaginalis
Open accessAbstract
SUMMARY: Infections with the sexually transmitted protozoan Trichomonas vaginalis are usually treated with metronidazole, a 5-nitroimidazole drug derived from the antibiotic azomycin. Metronidazole treatment is generally efficient in eliminating T. vaginalis infection and has a low risk of serious side effects. However, studies have shown that at least 5% of clinical cases of trichomoniasis are caused by parasites resistant to the drug. The lack of approved alternative therapies for T. vaginalis treatment means that higher and sometimes toxic doses of metronidazole are the only option for patients with resistant disease. Clearly, studies of the treatment and prevention of refractory trichomoniasis are essential. This review describes the mechanisms of metronidazole resistance in T. vaginalis and provides a summary of trichomonicidal and vaccine candidate drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Laga, M., Manoka, A., Kivuvu, M., Malele, B., Tuliza, M., Nzila, N., Goeman, J., Behets, F., Batter, V., Alary, M., et al. (1993) · AIDS · doi:10.1097/00002030-199301000-00015 · Cited by 1,139
Clinical and Microbiological Aspects of Trichomonas vaginalis
Petrin, D., Delgaty, K., Bhatt, R., & Garber, G. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.300 · Cited by 713
Self-citationNitroimidazole drugs-action and resistance mechanisms I. Mechanism of action
Edwards, D. I. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.1.9 · Cited by 606
Drug Targets and Mechanisms of Resistance in the Anaerobic Protozoa
Upcroft, P., & Upcroft, J. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.1.150-164.2001 · Cited by 565
Global prevalence and incidence estimates of selected curable STDs.
Gerbase, A. C., Rowley, J. T., Heymann, D., Berkley, S., & Piot, P. (1998) · PubMed · Cited by 524
Laga, M., Alary, M., Behets, F., Goeman, J., Piot, P., Nzila, N., Manoka, A. T., Tuliza, M., & St Louis, M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)93005-8 · Cited by 406
Trichomonas vaginalis: Reevaluation of Its Clinical Presentation and Laboratory Diagnosis
Fouts, A. C., & Kraus, S. J. (1980) · Journal of Infectious Diseases · doi:10.1093/infdis/141.2.137 · Cited by 343
Handbook of Animal Models of Infection
(1999) · Elsevier eBooks · doi:10.1016/b978-0-12-775390-4.x5136-7 · Cited by 283
Clinical Manifestations of Vaginal Trichomoniasis
Wølner-Hanssen, P. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420040109029 · Cited by 246
Antitrichomonad Action, Mutagenicity, and Reduction of Metronidazole and Other Nitroimidazoles
Lindmark, D. G., & Müller, M. (1976) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.10.3.476 · Cited by 235
Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence
Katiyar, S. K., Gordon, V. R., McLaughlin, G. L., & Edlind, T. D. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2086 · Cited by 217
Is metronidazole teratogenic? A meta‐analysis
Caro‐Patón, T., Carvajal, A., Martín de Diego, I., Martín‐Arias, L. H., Alvarez Requejo, A., & Pinilla, E. R. (1997) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1997.00660.x · Cited by 214
The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms
Ings, R. M. J., McFadzean, J. A., & Ormerod, W. E. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90362-1 · Cited by 200
Trichomonas vaginalis and amplification of HIV-1 transmission
Sorvillo, F., & Kerndt, P. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78181-2 · Cited by 193
Trichomonas Vaginalis: A Reemerging Pathogen
HEINE, P., & McGREGOR, J. A. (1993) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-199303000-00019 · Cited by 168
Trichomonads Parasitic in Humans
Honigberg, B. M. (1991) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199110000-00016 · Cited by 158
A population based case‐control teratologic study of oral metronidazole treatment during pregnancy
Czeizel, A. E., & Rockenbauer, M. (1998) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb10094.x · Cited by 155
The Reductive Metabolism of Metronidazole and Ronidazole by Aerobic Liver Microsomes
Perez‐Reyes, E., Kalyanaraman, B., & Mason, R. P. (1980) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14090-x · Cited by 135
Reductive activation of nitroimidazoles in anaerobic microorganisms
Müller, M. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90552-6 · Cited by 125
Lehker, M. W., Arroyo, R., & Alderete, J. F. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.2.311 · Cited by 118
In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis
Narcisi, E. M., & Secor, W. E. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1121 · Cited by 116
Connor, T. H., Stoeckel, M. E., Evrard, J. R., et al. (1977) · PubMed · Cited by 111
Pharmacokinetics of Metronidazole as Determined by Bioassay
Ralph, E. D., Clarke, J. T., Libke, R. D., Luthy, R. P., & Kirby, W. M. M. (1974) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.6.6.691 · Cited by 111
Kaneda, Y., Torii, M., Tanaka, T., & Aikawa, M. (1991) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1991.11812586 · Cited by 109
Müller, M., Lossick, J. G., & Gorrell, T. E. (1988) · Sexually Transmitted Diseases · doi:10.1097/00007435-198801000-00004 · Cited by 108
Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route
Mattila, J., Männistö, P. T., Mäntylä, R., Nykänen, S., & LAMMINSIVU, U. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.5.721 · Cited by 100
Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs.
Edwards, D. (1980) · Sexually Transmitted Infections · doi:10.1136/sti.56.5.285 · Cited by 89
Ellis, J. E., Yarlett, N., Cole, D., Humphreys, M. J., & Lloyd, D. (1994) · Microbiology · doi:10.1099/13500872-140-9-2489 · Cited by 88
COSAR, C., & Julou, L. (1959) · PubMed · Cited by 82
In Vitro Induced Anaerobic Resistance to Metronidazole In Trichomonas Vaginalis
Kulda, J., Tachezy, J., & Čerkasovová, A. (1993) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.1993.tb04915.x · Cited by 78
Land, K. M., Delgadillo‐Correa, M. G., Tachezy, J., Vaňáčová, Š., Hsieh, C. L., Šuťák, R., & Johnson, P. J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03791.x · Cited by 68
Metronidazole-resistant strains of Trichomonas vaginalis display increased susceptibility to oxygen
Rasoloson, D., Tomková, E., Cammack, R., Kulda, J., & Tachezy, J. (2001) · Parasitology · doi:10.1017/s0031182001008022 · Cited by 62
In vitro susceptibility of Trichomonas vaginalis to 50 antimicrobial agents
Sears, S. D., & O'Hare, J. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.1.144 · Cited by 61 · cited 1×
“Unfortunately, the level of toxicity exhibited by all three of these compounds is cause for concern and may limit their potential as intravaginal preparations; clearly, more research is required (111).”
BackgroundTreatment of Sexually Transmitted Vaginosis/Vaginitis
Lossick, J. G. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.supplement_6.s665 · Cited by 57
Epidemiology of Urogenital Trichomoniasis
Lossick, J. G. (1990) · Springer eBooks · doi:10.1007/978-1-4612-3224-7_17 · Cited by 52
In vitro reductive activation of nitroimidazoles
Declerck, P. J., & Ranter, C. J. D. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90555-1 · Cited by 50
McGrory, T., & Garber, G. E. (1992) · Infection and Immunity · doi:10.1128/iai.60.6.2375-2379.1992 · Cited by 46
Self-citationSexual transmission of HIV and the epidemiology of other sexually transmitted diseases
Cameron, D. W., & PADIAN, N. S. (1990) · AIDS · doi:10.1097/00002030-199001001-00016 · Cited by 46
Addis, M. F., Rappelli, P., de Andrade, A. M. P., Rita, F. M., Colombo, M. M., Cappuccinelli, P., & Fiori, P. L. (1999) · The Journal of Infectious Diseases · doi:10.1086/315095 · Cited by 45
Aerobic resistance ofTrichomonas vaginalisto metronidazole inducedin vitro
Tachezy, J., Kulda, J., & Tomková, E. (1993) · Parasitology · doi:10.1017/s0031182000074783 · Cited by 44
Clinical Manifestations of Urogenital Trichomoniasis in Women
Rein, M. F. (1990) · Springer eBooks · doi:10.1007/978-1-4612-3224-7_11 · Cited by 43
Inactivation of metronidazole by aerobic organisms
Edwards, D., THOMPSON, E. J., TOMUSANGE, J., & Shanson, D. C. (1979) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/5.3.315 · Cited by 41
Reactivity of Reduced [2Fe-2S] Ferredoxins Parallels Host Susceptibility to Nitroimidazoles
Vidakovic, M., Crossnoe, C. R., Neidre, C., Kim, K., Krause, K. L., & Germanas, J. P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.302-308.2003 · Cited by 41
Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis
Nix, D. E., Tyrrell, R. M., & Müller, M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1848 · Cited by 38
Enhanced antiparasitic activity of lipophilic tetracyclines: role of uptake
Katiyar, S. K., & Edlind, T. D. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.11.2198 · Cited by 35
Muscará, M. N., Pedrazzoli, J., Miranda, E., et al. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05792.x · Cited by 26
ZINC AND RECALCITRANT TRICHOMONIASIS
Willmott, F. E., Say, J., Downey, D., & Hookham, A. B. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92684-3 · Cited by 24
Ryu, J., & Lloyd, D. (1995) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1995.tb07717.x · Cited by 21
Managing trichomonal vaginitis refractory to conventional treatment with metronidazole.
Ahmed-Jushuf, I. H., Murray, A. E., & McKeown, J. (1988) · Sexually Transmitted Infections · doi:10.1136/sti.64.1.25 · Cited by 18
Infectious vaginitis. Selecting therapy and preventing recurrence.
Goode, M. A., Grauer, K., & Gums, J. G. (1994) · PubMed · Cited by 7
Infectious vaginitis: Selecting therapy and preventing recurrence
Goode, M. A., Grauer, K., & Gums, J. G. (1994) · Postgraduate Medicine · doi:10.1080/00325481.1994.11945924 · Cited by 6
Winkelstein, W., & Johnson, A. M. (1990) · AIDS · doi:10.1097/00002030-199001001-00015 · Cited by 4
Metadata
- Authors
- Cudmore, S. L., Delgaty, K. L., Hayward-McClelland, S. F., Petrin, D. P., & Garber, G. E.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2004-10
- Volume
- 17
- Issue
- 4
- Pages
- 783-793
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2097304393
- Cited by
- 306
- References
- 52
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.